Nanoparticle-and liposome-carried drugs: New strategies for active targeting and drug delivery across blood-brain barrier

The blood-brain barrier (BBB), the unusual microvascular endothelial interface between the central nervous system (CNS) and the circulatory system, is a major hindrance to drug delivery in the brain parenchyma. Besides the absence of fenestrations and the abundance of tight junctions, ATP-binding ca...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2013

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/23802

Acceso en línea:

https://doi.org/10.2174/1389200211314060001
https://repository.urosario.edu.co/handle/10336/23802

Palabra clave:

Dactinomycin
Dasatinib
Daunorubicin
Docetaxel
Doxorubicin
Epirubicin
Erlotinib
Etoposide
Gefitinib
Indinavir
Irinotecan
Ketoconazole
Lamivudine
Lapatinib
Liposome
Methotrexate
Mitoxantrone
Nanoparticle
Nelfinavir
Paclitaxel
Probenecid
Saquinavir
Sorafenib
Teniposide
Topotecan
Unindexed drug
Verlukast
Vinblastine
Vincristine
Zidovudine
Blood brain barrier
Controlled drug release
Degenerative disease
Drug coating
Drug degradation
Drug delivery system
Drug distribution
Drug mechanism
Drug penetration
Drug synthesis
Drug targeting
Epilepsy
Gene therapy
Glioblastoma
Human
Human immunodeficiency virus infection
Hydrophilicity
Hydrophobicity
In vivo study
Lipophilicity
Nanoencapsulation
Nonhuman
Parenchyma
Physical chemistry
Review
Surface property
Animals
Atp-binding cassette transporters
Biological transport
Blood-brain barrier
Humans
Liposomes
Nanoparticles
Pharmaceutical preparations
Atp-binding cassette transporters
Blood-brain barrier
Central nervous system
Drug delivery
Liposomes
Nanoparticles

Rights

License

Abierto (Texto Completo)